RxDoctor Payments Data

Amy Labib

Family · Alpharetta, GANPI 1013696152

Payments from drug & device makers

$4,370in general payments, 2019–2025

Across 186 payments — averaging $23.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$547
  • Amgen$485
  • Lilly USA, LLC$422
  • Sanofi-aventis U.S. LLC$410
  • Cequr Corporation$364
  • Insulet Corporation$339
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$4,370100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,370 in reported general payments places this provider in the 90th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide62$77,040
OzempicSemaglutide27$35,181
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,663
Levothyroxine Sodium34$149
Liothyronine Sodium12$102
Metformin Hcl20$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$422$77,04062 claims
Novo NordiskOzempic$547$35,18127 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$17$14934 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,258 family providers in Georgia.

Other family in Alpharetta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →